Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion [NA]

View source ↗

Summary

Clinical trial evaluating Restylane Defyne for chin augmentation and chin retrusion completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chin Augmentation
• Chin Retrusion

Drugs mentioned

• Restylane Defyne (hyaluronic acid dermal filler)

Snippet

Sponsor: Galderma R&D | Conditions: Chin Retrusion, Chin Augmentation | NA | Status: COMPLETED | Results posted: 2022-10-06